Available safety data showed no increase in serious cardiovascular events during 68 weeks of treatment
Exendin-4 became the chemical scaffold for exenatide, and on April 28, 2005, the FDA approved exenatide (Byetta) for type 2 diabetes the first GLP-1 receptor agonist ever marketed
Its a reflection of a deeper understanding in healthcare that patient experience is just as crucial as treatment efficacy
Conversely, achieving a healthier weight through modest weight loss (typically 5-10% of body weight) has been shown to improve fertility outcomes significantly
Insert the needle at a 90-degree angle (straight in, perpendicular to your skin) for proper subcutaneous delivery
If you are interested in learning whether retatrutide injections may be right for you, call (602) 595-7836 or schedule a consultation with Revive Wellness and Rejuvenation today and take the next step toward living your healthiest life